Dose intensification in hormone receptor-negative and/or human epidermal growth factor receptor 2-negative high-risk primary breast cancer

Ugo De Giorgi, Dino Amadori

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)758
Number of pages1
JournalJournal of Clinical Oncology
Issue number7
Publication statusPublished - Mar 1 2012

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this